Journal profile · Medicine-Pharmacology (medical)
Cancer and Chemotherapy Reviews
ISSN 1885-740X · eISSN 2339-8728 · Permanyer Publication
Cancer and Chemotherapy Reviews: subscription journal; 1 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Cancer and Chemotherapy Reviews is published by Permanyer Publication. By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment and Acute Myeloid Leukemia Research, together about 50% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Pharmacology (medical)
Editor-in-chief Eduardo Díaz-Rubio MadridPublisher website
Editorial board by country: none in mainland China; most named Spain 4, South Africa 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine16.7%
- Sarcoma Diagnosis and TreatmentMedicine16.7%
- Acute Myeloid Leukemia ResearchMedicine16.7%
- Acute Lymphoblastic Leukemia researchMedicine16.7%
- Cancer Treatment and PharmacologyMedicine16.7%
- Cancer therapeutics and mechanismsBiochemistry, Genetics and Molecular Biology16.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Oncology | Q4 | 399/428 | 6th |
| Pharmacology (medical) | Q4 | 260/278 | 6th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.3LetPub ·
- SJR 2026-06
- 0.1LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 0OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 3 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1 | 0 | 0 |
| 2025 | 1 | 1 | 0 |
| 2024 | 1 | 1 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Open access, Peer review
- Authorship
Original, unpublished work only; no simultaneous submission. Model summary
La publicación de un manuscrito en la Revista Cancer & Chemotherapy Reviews implica el compromiso, por parte de los autores, de que no ha sido publicado previamente y que no está pendiente por publicarse mediante algún otro medio, sea impreso o electrónico.
Source ↗Publisher website ·- Conflicts of interest
Cover letter must include a clear conflict-of-interest statement. Model summary
Debe incluir un enunciado claro sobre algún potencial conflicto de interés y cuál es, y debe ir firmada por el autor principal.
Source ↗Publisher website ·- Open access
Open access and licensing page exists Model summary
ACCESO ABIERTO Y LICENCIA / OPEN ACCESS & LICENSING
Source ↗Publisher website ·- Peer review
Acknowledgments and funding on the front page to keep the manuscript anonymous. Model summary
Agradecimientos: en esta sección se describirán los agradecimientos a personas e instituciones, así como los financiamientos. Este apartado debe ir en la página frontal para que el documento principal del manuscrito siga siendo anónimo.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Permanyer Publication
- ISSN
- 1885-740X
- Electronic ISSN
- 2339-8728
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Cancer and Chemotherapy Reviews
Where are the editorial board members of Cancer and Chemotherapy Reviews based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (4) and South Africa (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Cancer and Chemotherapy Reviews?
According to LetPub and DOAJ records, Cancer and Chemotherapy Reviews is indexed in Scopus.
Is Cancer and Chemotherapy Reviews open access, and what is the APC?
Cancer and Chemotherapy Reviews is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .